ArticleModern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc2020

BRAF V600E mutation is a potential therapeutic target for a small subset of synovial sarcoma.

Sho Watanabe et al.PubMed ↗Publisher ↗

No numbers read from the abstract.